HYPERION DEFI, INC. Operating Lease, Payments
HYPERION DEFI, INC. (HYPD) reported Operating Lease, Payments of $574.06 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-30
- HYPERION DEFI, INC. operating lease, payments for the quarter ending 2024-12-31 was $148.41K, a 61.71% increase year-over-year.
- HYPERION DEFI, INC. operating lease, payments for the quarter ending 2024-09-30 was $143.14K, a 13.36% increase year-over-year.
- HYPERION DEFI, INC. operating lease, payments for the quarter ending 2024-06-30 was $135.60K, a 8.90% decline year-over-year.
- HYPERION DEFI, INC. operating lease, payments for the quarter ending 2024-03-31 was $74.10K, a 45.57% decline year-over-year.
- HYPERION DEFI, INC. operating lease, payments for fiscal 2025 was $574.06K, a 14.53% increase from fiscal 2024.
- HYPERION DEFI, INC. operating lease, payments for fiscal 2024 was $501.25K, a 0.36% decline from fiscal 2023.
- HYPERION DEFI, INC. operating lease, payments for fiscal 2023 was $503.05K, a 21.96% increase from fiscal 2022.
- HYPERION DEFI, INC. operating lease, payments for fiscal 2022 was $412.48K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $574.06K 10-K · filed 2026-03-30 | |||
| 2024-12-31 | $148.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $291.55K derived: sum of 2 quarters · filed 2026-03-30 | $427.15K derived: sum of 3 quarters · filed 2026-03-30 | $501.25K 10-K · filed 2026-03-30 |
| 2024-09-30 | $143.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $278.74K derived: sum of 2 quarters · filed 2024-11-12 | $352.84K 10-Q · filed 2024-11-12 | $444.62K derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-06-30 | $135.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $209.70K 10-Q · filed 2024-08-14 | $301.48K derived: sum of 3 quarters · filed 2025-04-15 | $427.75K derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-03-31 | $74.10K 10-Q · filed 2024-05-15 | $165.88K derived: sum of 2 quarters · filed 2025-04-15 | $292.15K derived: sum of 3 quarters · filed 2025-04-15 | $441.00K derived: sum of 4 quarters · filed 2025-04-15 |
| 2023-12-31 | $91.78K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $218.05K derived: sum of 2 quarters · filed 2025-04-15 | $366.90K derived: sum of 3 quarters · filed 2025-04-15 | $503.05K 10-K · filed 2025-04-15 |
| 2023-09-30 | $126.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $275.12K derived: sum of 2 quarters · filed 2024-11-12 | $411.27K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $148.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $285.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $136.15K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $412.48K 10-K · filed 2024-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |